Ear-Nose-Throat (ENT) Devices Market Size By Product Type (Diagnostic Ear, Nose, And Throat (ENT) Devices [Rigid Endoscopes {Rhinoscopes, Laryngoscopes, Otological Endoscopes}, Flexible Endoscopes, Robot Assisted Endoscope, Hearing Screening Device], Surg

Ear-Nose-Throat (ENT) Devices Market Size By Product Type (Diagnostic Ear, Nose, And Throat (ENT) Devices [Rigid Endoscopes {Rhinoscopes, Laryngoscopes, Otological Endoscopes}, Flexible Endoscopes, Robot Assisted Endoscope, Hearing Screening Device], Surgical Ear, Nose, And Throat (ENT) Devices [Radiofrequency Handpieces, Powered Surgical Instrument, Otological Drill Burrs, ENT Hand Instruments, Tympanostomy Tubes, Sinus Dilation Devices, Nasal Packing Devices], Hearing Aids {In-The-Ear (ITE), Receiver ITE, Behind-The-Ear, Canal Hearing Aids ITC, CIC, IIC}, Hearing Implants {Auditory Brainstem Implants, Cochlear Implants, Middle Ear Implants, Bone Anchored Hearing System}, Voice Prosthesis Devices, Nasal Splints {Internal Nasal Splints, External Nasal Splints}), Industry Analysis Report, Regional Outlook (U.S. Canada, UK, Germany, France, Italy, Spain, China, India, Japan, Brazil, Mexico, South Africa, Saudi Arabia, UAE), Application Potential, Competitive Market Share & Forecast, 2019 - 2025

Ear-Nose-Throat (ENT) Devices Market will exceed USD 26 billion by 2025; as per a new research report.

Rising prevalence of ear, nose and throat disorders among adult population is the foremost driving factor for ENT devices market. As per Hearing Loss Association of America (HLAA) and CDC, hearing loss is the third most prevalent form of health issue after heart disease and arthritis among the adult population base. According to HLAA report, around 25% Americans have experienced tinnitus, these people are prone to hearing loss. Thus, increasing prevalence of such diseases will enhance the demand of ENT devices. Sinusitis is one of the most common disorder that causes inflammation in cavities around nasal passage. As reported by CDC, 12.1% of adult Americans are diagnosed with sinusitis that raises the demand for superior quality ENT devices such as sinus dilation systems. Aforementioned factors coupled with increasing prevalence of pharyngitis and throat cancer will further drive the industry growth.

Technological advancements in ENT devices such as diagnostic devices, hearing aid and sinus dilation devices will propel the industry growth. For instance, Medtronic has developed surgical devices such as otological burrs and drills that possess high accuracy and are user friendly. Moreover, recently developed endoscopes and navigation systems assist otolaryngologists throughout complex invasive surgical procedures. Also, increased use of digital signal processing incorporated with new applications in hearing aids and implants offers numerous benefits to hearing impaired population. However, high cost of ENT devices as well as surgical procedure will impede industry growth to some extent.

Nasal splints segment is expected to grow at 5.1% throughout the forecast period. Nasal splints are used to maintain nasal structure and allows nasal breathing post-operatively through the integral airway. Nasal splints are widely used in surgical procedures to stabilize healing septum and offer septal compression. Also, nasal splints protect nose from trauma and retains bone position that will raise its adoption thereby, accelerating the segmental growth.

Flexible diagnostic endoscopes segment was valued at USD 1.1 billion in 2018. Wide range of application of flexible endoscopy in micro-invasive methods will drive the flexible endoscope segmental growth over analysis timeframe. Newly developed flexible endoscopes enhances patient’s safety and also helps in minimizing patient’s exposure to chemical germicide and other microbial infections that will positively impact the demand for flexible endoscopes.

Europe ENT devices market will experience 7.3% growth during the analysis period. Stupendous regional market growth is attributed to growing elderly population base suffering from ENT diseases. Rhinosinusitis is the most prevalent disease in the European elderly population. Hence, European government implements certain initiatives that enables optimum reduction in its surgical costs. Aforementioned factors coupled with presence of regulatory authorities such as EU commission to review the quality of ENT devices has augmented the European market growth during the forecast timeframe. Startup companies willing to operate in ENT devices industry can also grab potential market share due to ever increasing demand for ENT devices along with favorable trade policies.

Eminent industry players operational in Ear-Nose-Throat market includes Atos Medical, Cochlear Limited, GN Hearing A/S, Rion Co. Ltd, Siemen’s Healthcare, Sonova, Starkey Hearing Technologies, Welch Allyn, Widex A/S, William Demant Holding A/S. These industry players adopt strategies such as new product launch, mergers and acquisition to sustain market position. For instance, in August 2018, William Demant launched Oticon Opn, the most advanced hearing aid solution that will boost firm’s product portfolio.